Hillsdale Investment Management’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.15M | Buy |
2,440
+350
| +17% | +$176K | 0.03% | 346 |
|
|
2025
Q4 | $976K | Buy |
+2,090
| New | +$970K | 0.03% | 372 |
|
|
2025
Q1 | – | Sell |
-2,045
| Closed | -$614K | – | 640 |
|
|
2024
Q4 | $614K | Hold |
2,045
| – | – | 0.03% | 339 |
|
|
2024
Q3 | $831K | Buy |
2,045
+150
| +8% | +$54.9K | 0.06% | 247 |
|
|
2024
Q2 | $609K | Buy |
+1,895
| New | +$616K | 0.05% | 275 |
|
|
2024
Q1 | – | Sell |
-1,845
| Closed | -$499K | – | 633 |
|
|
2023
Q4 | $499K | Sell |
1,845
-200
| -10% | -$49.4K | 0.04% | 303 |
|
|
2023
Q3 | $503K | Buy |
2,045
+400
| +24% | +$109K | 0.05% | 270 |
|
|
2023
Q2 | $499K | Hold |
1,645
| – | – | 0.05% | 240 |
|
|
2023
Q1 | $434K | Buy |
+1,645
| New | +$418K | 0.04% | 350 |
|
|
2021
Q3 | – | Sell |
-3,060
| Closed | -$632K | – | 596 |
|
|
2021
Q2 | $632K | Sell |
3,060
-400
| -12% | -$81.5K | 0.05% | 329 |
|
|
2021
Q1 | $652K | Sell |
3,460
-50
| -1% | -$8.82K | 0.05% | 296 |
|
|
2020
Q4 | $577K | Buy |
3,510
+100
| +3% | +$14.6K | 0.05% | 306 |
|
|
2020
Q3 | $425K | Hold |
3,410
| – | – | 0.04% | 359 |
|
|
2020
Q2 | $331K | Sell |
3,410
-300
| -8% | -$31.2K | 0.03% | 387 |
|
|
2020
Q1 | $333K | Hold |
3,710
| – | – | 0.04% | 371 |
|
|
2019
Q4 | $548K | Buy |
3,710
+60
| +2% | +$8.06K | 0.05% | 323 |
|
|
2019
Q3 | $439K | Sell |
3,650
-200
| -5% | -$25.8K | 0.04% | 378 |
|
|
2019
Q2 | $520K | Buy |
3,850
+3,790
| +6,317% | +$479K | 0.05% | 325 |
|
|
2019
Q1 | $8K | Sell |
60
-4,080
| -99% | -$548K | ﹤0.01% | 500 |
|
|
2018
Q4 | $514K | Sell |
4,140
-300
| -7% | -$40.3K | 0.06% | 187 |
|
|
2018
Q3 | $618K | Hold |
4,440
| – | – | 0.08% | 157 |
|
|
2018
Q2 | $455K | Buy |
4,440
+460
| +12% | +$46.5K | 0.06% | 204 |
|
|
2018
Q1 | $386K | Buy |
3,980
+3,900
| +4,875% | +$378K | 0.05% | 225 |
|
|
2017
Q4 | $7K | Sell |
80
-610
| -88% | -$49K | ﹤0.01% | 381 |
|
|
2017
Q3 | $55K | Sell |
690
-3,400
| -83% | -$273K | 0.01% | 315 |
|
|
2017
Q2 | $356K | Sell |
4,090
-1,530
| -27% | -$129K | 0.07% | 219 |
|
|
2017
Q1 | $500K | Hold |
5,620
| – | – | 0.1% | 165 |
|
|
2016
Q4 | $416K | Hold |
5,620
| – | – | 0.09% | 179 |
|
|
2016
Q3 | $425K | Hold |
5,620
| – | – | 0.11% | 182 |
|
|
2016
Q2 | $432K | Sell |
5,620
-200
| -3% | -$15.8K | 0.13% | 127 |
|
|
2016
Q1 | $454K | Buy |
5,820
+870
| +18% | +$60.8K | 0.15% | 102 |
|
|
2015
Q4 | $335K | Sell |
4,950
-800
| -14% | -$55.8K | 0.13% | 229 |
|
|
2015
Q3 | $445K | Buy |
5,750
+800
| +16% | +$70.8K | 0.15% | 116 |
|
|
2015
Q2 | $449K | Hold |
4,950
| – | – | 0.14% | 137 |
|
|
2015
Q1 | $372K | Buy |
4,950
+1,000
| +25% | +$71.8K | 0.1% | 192 |
|
|
2014
Q4 | $290K | Hold |
3,950
| – | – | 0.07% | 249 |
|
|
2014
Q3 | $279K | Buy |
+3,950
| New | +$261K | 0.09% | 210 |
|
Other funds holding HCA
VCM
VPM
Hillsdale Investment Management's HCA Position: Q1 2026 in Review
Hillsdale Investment Management increased its HCA Healthcare (HCA) stake by 17% in Q1 2026, buying an estimated $176K and bringing the position to 2,440 shares worth $1.15M. The position accounts for 0.03% of the portfolio, ranked #346.
Hillsdale Investment Management first reported a position in HCA in Q3 2014 and has held it in 37 quarters since. 1,415 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- Hillsdale Investment Management held 2,440 shares of HCA Healthcare worth $1.15M as of Q1 2026.
- Hillsdale Investment Management bought 350 HCA Healthcare shares in Q1 2026, an estimated $176K.
- HCA Healthcare made up 0.03% of Hillsdale Investment Management's portfolio in Q1 2026, its #346 holding.
- Hillsdale Investment Management first reported a position in HCA Healthcare in Q3 2014 and has held it in 37 quarters since.
- 1,415 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on Hillsdale Investment Management's 13F filing for Q1 2026, filed 4 May 2026.